ClinicalTrials.Veeva

Menu
M

Magnolia Clinical Research, LLC. | Cary, NC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Azetukalner
ACP-211
SP-624
KarXT
Seltorexant
Trospium Chloride
Xanomeline

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...

Enrolling
Major Depressive Disorder
Drug: Azetukalner
Drug: Placebo

The main purpose of this study is to assess how well the study drug (JNJ-42847922) works (efficacy) compared with placebo in improving depressive sym...

Enrolling
Depressive Disorder, Major
Drug: Placebo
Drug: Seltorexant

The goal of this clinical trial is to learn if ACP-211 can help treat adults with major depressive disorder (MDD) who have not improved with antidepr...

Enrolling
Depressive Disorder, Treatment-Resistant
Major Depressive Disorder (MDD)
Drug: ACP-211
Drug: Placebo

X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult p...

Invitation-only
Major Depressive Disorder
Drug: Azetukalner

Trial sponsors

X
Acadia Pharmaceuticals logo
Bristol-Myers Squibb (BMS) logo
Janssen (J&J Innovative Medicine) logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems